Cargando…

Pharmacological Characterization of Low-to-Moderate Affinity Opioid Receptor Agonists and Brain Imaging with (18)F-Labeled Derivatives in Rats

[Image: see text] The 3,4-dichloro-N-(1-(dimethylamino)cyclohexyl)methyl benzamide scaffold was studied as a template for (18)F-positron emission tomography ((18)F-PET) radiotracer development emphasizing sensitivity to changes in opioid receptor (OR) occupancy over high affinity. Agonist potency, b...

Descripción completa

Detalles Bibliográficos
Autores principales:	Ott, Julian, Spilhaug, Mona M., Maschauer, Simone, Rafique, Waqas, Jakobsson, Jimmy E., Hartvig, Karoline, Hübner, Harald, Gmeiner, Peter, Prante, Olaf, Riss, Patrick J.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	American Chemical Society 2020
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7497404/ https://www.ncbi.nlm.nih.gov/pubmed/32787100 http://dx.doi.org/10.1021/acs.jmedchem.0c00683

Ejemplares similares

Synthesis, Radiosynthesis and Biological Evaluation of Buprenorphine‐Derived Phenylazocarboxamides as Novel μ‐Opioid Receptor Ligands
por: Krüll, Jasmin, et al.
Publicado: (2020)

[(18)F]Fluorophenylazocarboxylates: Design and Synthesis of Potential Radioligands for Dopamine D3 and μ-Opioid Receptor
por: Nebel, Natascha, et al.
Publicado: (2017)

Theranostic Value of Multimers: Lessons Learned from Trimerization of Neurotensin Receptor Ligands and Other Targeting Vectors
por: Maschauer, Simone, et al.
Publicado: (2017)

In Vivo Monitoring of the Antiangiogenic Effect of Neurotensin Receptor-Mediated Radiotherapy by Small-Animal Positron Emission Tomography: A Pilot Study
por: Maschauer, Simone, et al.
Publicado: (2014)

Sweetening Pharmaceutical Radiochemistry by (18)F-Fluoroglycosylation: A Short Review
por: Maschauer, Simone, et al.
Publicado: (2014)

PET Radiopharmaceuticals for Imaging Integrin Expression: Tracers in Clinical Studies and Recent Developments
por: Haubner, Roland, et al.
Publicado: (2014)

Sweetening Pharmaceutical Radiochemistry by (18)F-Fluoroglycosylation: Recent Progress and Future Prospects
por: Shinde, Sandip S., et al.
Publicado: (2021)

H-CRRETAWAC-OH, a Lead Structure for the Development of Radiotracer Targeting Integrin α (5) β (1)?
por: Haubner, Roland, et al.
Publicado: (2014)

(18)F-labelled triazolyl-linked argininamides targeting the neuropeptide Y Y(1)R for PET imaging of mammary carcinoma
por: Maschauer, Simone, et al.
Publicado: (2019)

Image-Guided Development of Heterocyclic Sulfoxides as Ligands for Tau Neurofibrillary Tangles: From First-in-Man to Second-Generation Ligands
por: Rafique, Waqas, et al.
Publicado: (2018)

Structure‐Based Evolution of G Protein‐Biased μ‐Opioid Receptor Agonists
por: Wang, Haoqing, et al.
Publicado: (2022)

Bivalent ligands promote endosomal trafficking of the dopamine D3 receptor-neurotensin receptor 1 heterodimer
por: Budzinski, Julian, et al.
Publicado: (2021)

(18)F-Fluorination Using Tri-Tert-Butanol Ammonium Iodide as Phase-Transfer Catalyst: An Alternative Minimalist Approach
por: Shinde, Sandip S., et al.
Publicado: (2021)

In Vitro and In Vivo Characterization of Selected Fluorine-18 Labeled Radioligands for PET Imaging of the Dopamine D3 Receptor
por: Nebel, Natascha, et al.
Publicado: (2016)

Recent Trends in Pharmaceutical Radiochemistry for Molecular PET Imaging
por: Prante, Olaf, et al.
Publicado: (2014)

Neurotensin analogs by fluoroglycosylation at N(ω)-carbamoylated arginines for PET imaging of NTS1-positive tumors
por: Schindler, Lisa, et al.
Publicado: (2022)

Photochromic Fentanyl Derivatives for Controlled μ‐Opioid Receptor Activation
por: Lahmy, Ranit, et al.
Publicado: (2022)

Full Opioid Agonists and Tramadol: Pharmacological and Clinical Considerations
por: Edinoff, Amber N., et al.
Publicado: (2021)

Heterodimerization of Dibenzodiazepinone-Type Muscarinic Acetylcholine Receptor Ligands Leads to Increased M(2)R Affinity and Selectivity
por: She, Xueke, et al.
Publicado: (2017)

μ-opioid receptor agonists and psychedelics: pharmacological opportunities and challenges
por: Salinsky, Leah M., et al.
Publicado: (2023)

Transition metal free, late-stage, regiospecific, aromatic fluorination on a preparative scale using a KF/crypt-222 complex
por: Jakobsson, Jimmy Erik, et al.
Publicado: (2018)

Identification of the Beer Component Hordenine as Food-Derived Dopamine D2 Receptor Agonist by Virtual Screening a 3D Compound Database
por: Sommer, Thomas, et al.
Publicado: (2017)

Predicting opioid receptor binding affinity of pharmacologically unclassified designer substances using molecular docking
por: Ellis, Christopher R., et al.
Publicado: (2018)

Tianeptine, an Antidepressant with Opioid Agonist Effects: Pharmacology and Abuse Potential, a Narrative Review
por: Edinoff, Amber N., et al.
Publicado: (2023)

Novel multi-objective affinity approach allows to identify pH-specific μ-opioid receptor agonists
por: Secker, Christopher, et al.
Publicado: (2023)

Enantiomerically Pure Quinoline‐Based κ‐Opioid Receptor Agonists: Chemoenzymatic Synthesis and Pharmacological Evaluation
por: Martin, Benedikt, et al.
Publicado: (2020)

Selectively Promiscuous Opioid Ligands: Discovery of High Affinity/Low Efficacy Opioid Ligands with Substantial Nociceptin Opioid Peptide Receptor Affinity
por: Kumar, Vinod, et al.
Publicado: (2014)

Fluorescence Labeling of Neurotensin(8–13) via Arginine Residues Gives Molecular Tools with High Receptor Affinity
por: Keller, Max, et al.
Publicado: (2019)

Synthesis and Pharmacological Activities of 6-Glycine Substituted 14-Phenylpropoxymorphinans, a Novel Class of Opioids with High Opioid Receptor Affinities and Antinociceptive Potencies
por: Spetea, Mariana, et al.
Publicado: (2011)

Non-Invasive Characterization of Experimental Bone Metastasis in Obesity Using Multiparametric MRI and PET/CT
por: Gregoric, Gasper, et al.
Publicado: (2022)

Better agonist for the opioid receptors
por: Badshah, Syed Lal, et al.
Publicado: (2018)

Synthesis and Characterization in Rodent Brain of the Subtype-Selective NR2B NMDA Receptor Ligand [(11)C]Ro04-5595 as a Potential Radiotracer for Positron Emission Tomography
por: Jakobsson, Jimmy E., et al.
Publicado: (2019)

5-Benzyl substituted 14-methoxymetopon, a high affinity μ opioid receptor agonist with potent antinociceptive activity in mice
por: Spetea, Mariana, et al.
Publicado: (2008)

Exploring pharmacological activities and signaling of morphinans substituted in position 6 as potent agonists interacting with the μ opioid receptor
por: Ben Haddou, Tanila, et al.
Publicado: (2014)

Pharmacological characterization of cebranopadol a novel analgesic acting as mixed nociceptin/orphanin FQ and opioid receptor agonist
por: Rizzi, Anna, et al.
Publicado: (2016)

Synthesis, Pharmacology, and Molecular Docking Studies on 6-Desoxo-N-methylmorphinans as Potent μ-Opioid Receptor Agonists
por: Dumitrascuta, Maria, et al.
Publicado: (2017)

Synthesis and Pharmacological Evaluation of Fluorinated Quinoxaline‐Based κ‐Opioid Receptor (KOR) Agonists Designed for PET Studies
por: Tangherlini, Giovanni, et al.
Publicado: (2020)

Alcohol use in opioid agonist treatment
por: Nolan, Seonaid, et al.
Publicado: (2016)

Therapeutic Potential of Kappa Opioid Agonists
por: Beck, Tyler C., et al.
Publicado: (2019)

Selective and Wash‐Resistant Fluorescent Dihydrocodeinone Derivatives Allow Single‐Molecule Imaging of μ‐Opioid Receptor Dimerization
por: Gentzsch, Christian, et al.
Publicado: (2020)

Cannot write session to /tmp/vufind_sessions/sess_3p5k7lduqkgbot7lm28h4pmupa